TORONTO - A powerful new narcotic some lawmakers fear will lead to a wave of abuse south of the border may soon be on the market in Canada. Mark Beaudet, president of Montreal-based pharmaceutical company Paladin Labs Inc., told the Toronto Sun the firm will apply to market Zohydro ER in Canada. Beaudet did not say when the application for the prescription painkiller will be filed with Health Canada........ TO SEE THE FULL ORIGINAL ARTICLE, CLICK ANYWHERE ON TEXT ...